BIOMAT Database Logo BIOMAT Database Logo

Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF. 1999

D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Neuroscience Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex, UK. declan_jones-1@sbphrd.com

The effects of the corticotropin-releasing factor (CRF) receptor antagonists, alpha-helical CRF-(9-41), [D-Phe12,Nle21,38, CalphaMe-Leu37]humanCRF-(12-41) (D-PheCRF-(12-41)) and astressin ([cyclo(30-33)[D-Phe12,Nle21,38,Glu30,Lys33]h umanCRF-(12-41) upon hypophagic and motor activation response to human/ratCRF (h/rCRF) were investigated. All three antagonists (100 microg intracerebroventricular (i.c.v.)) blocked the effects of h/rCRF (1 microg i.c.v.) upon food intake and body weight change in food-deprived rats. In contrast, alpha-helical CRF-(9-41) and astressin (both at 100 microg i.c.v., but not lower doses), but not D-PheCRF-(12-41) (up to 100 microg i.c.v.), blocked h/rCRF (0.3 microg i.c.v.)-induced motor activation in rats in a familiar environment. The ability of D-PheCRF-(12-41) to block CRF-induced hypophagia, but not motor activation, suggests a selective action of this antagonist upon the behavioural effects of centrally administered h/rCRF.

UI MeSH Term Description Entries
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005508 Food Deprivation The withholding of food in a structured experimental situation. Deprivation, Food,Deprivations, Food,Food Deprivations
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D006727 Hormone Antagonists Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. Antagonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Behavioural effects of NMDA-receptor antagonists.
January 1994, Journal of neural transmission. Supplementum,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Non-peptide CRF-Receptor Antagonists: Allosterism, Kinetics and Translation to Efficacy in Human Disease.
January 2017, Current molecular pharmacology,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
The behavioural and electrophysiological effects of CRF in rat frontal cortex.
January 2008, Neuropeptides,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Prospective Clinical Applications of CRF Peptide Antagonists.
January 2017, Current molecular pharmacology,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Are CRF receptor antagonists potential antidepressants?
January 2001, Human psychopharmacology,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Peptide antagonists of the human estrogen receptor.
July 1999, Science (New York, N.Y.),
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
October 1997, British journal of pharmacology,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
2-Arylpyrimidines: novel CRF-1 receptor antagonists.
August 2008, Bioorganic & medicinal chemistry letters,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
October 2002, Journal of medicinal chemistry,
D N Jones, and R Kortekaas, and P D Hatcher, and D N Middlemiss, and A White, and J J Hagan
Behavioural effects of some morphine antagonists and hallucinogens in the rat.
November 1968, Nature,
Copied contents to your clipboard!